90491 ⎘
Indexing scheme relating to specific properties of organic compounds Optical isomers
PROCESS FOR THE PREPARATION OF DIHYDROPYRROLE DERIVATIVES
#902Method for producing novel organometallic complex and amine compound
#903Fatty alcohol esters of hydroxycarboxylic acids
#904Homochiral metal-organic framework with enantiopure pillar[5]arene active domains
#905Cyclopropylamine derivatives useful as LSD1 inhibitors
#906P2X7 modulators and methods of use
#907Process for preparing lacosamide
#908Pharmaceutical compositions comprising monoterpenes
#909Stereodynamic chemosensors
#910Antiviral agents against HBV infection
#911Inhibitors of indoleamine 2,3-dioxygenase (IDO)
#912Process for the synthesis of melphalan and the hydrochloride salt
#913METHOD OF PRODUCING OPTICALLY ACTIVE TRANS-1,2-DIAMINOCYCLOHEXANE
#914Process for preparing substituted phenylalkanes
#915Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions
#9163′-substituted-abscisic acid derivatives
#917Synthesis of Tetracyclines and intermediates thereto
#918Method of producing optically-active aldehyde
#919Catalyst and method for producing optically active anti-1,2-nitroalkanol compound
#920Pharmaceutical compositions comprising monoterpenes
#921Enantioselective process for the preparation of enantiomers of sex pheromones
#922Methods and devices for using isoperillyl alcohol
#923Pesticidal compositions and processes related thereto
#924Cathepsin L inhibitors and probes comprising vinyl sulfonate moiety and methods of using same
#925NOVEL BENZODIOXANE-PIPERIDINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS FOR TREATING NEUROPSYCHIATRIC DISORDERS
#926Desferrithiocin polyether analogues
#927Synthetic route to pactamycin and pactamycin analogs
#928Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient
#929(6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one
#930(6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14 trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one
#931METHOD FOR PRODUCING OPTICALLY ACTIVE ISOPULEGOL AND OPTICALLY ACTIVE MENTHOL
#932Substituted xanthine derivatives
#933P2X7 modulators
#934Using mixtures of E/Z isomers to obtain quantitatively specific products by combined asymmetric hydrogenations
#935Efficient process of asymmetric hydrogenation of unsaturated ketones using additives
#936Bicyclic compounds
#937S1P and/or ATX modulating agents
#938DERIVATIVES OF (-)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME
#939Solid state forms of tapentadol salts
#940Chiral fluorinating reagents
#941Process for the preparation of intermediates useful for the manufacture NEP inhibitors
#942Method for producing racemate of compound
#943Method of producing chiral N-substituted allylic amine compounds
#944ATX modulating agents
#945Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof
#946DRUG SUBSTANCE PREPARATIONS, PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS COMPRISING S-(+)-FLURBIPROFEN
#947Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
#948Preparation method for optically active bicyclic gamma-amino acid compound
#949ATX modulating agents
#950Process for preparing intermediates useful in the manufacture of NEP inhibitors
#951Compounds that are S1P modulating agents and/or ATX modulating agents
#952Histone deacetylase inhibitors and compositions and methods of use thereof
#953Methods of synthesizing alpha acids and substantially enantiomerically pure compositions thereof
#954Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
#955Synthesis of chiral amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds
#956Alpha- and gamma-truxillic acid derivatives and pharmaceutical compositions thereof
#957Chiral phosphines for palladium-catalyzed asymmetric α-arylation of ester enolates to produce tertiary stereocenters in high enantioselectivity
#958Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#959Iron catalysts with unsymmetrical PNN'P ligands
#960Process for making amino acid compounds
#961Methods and compositions for the synthesis of multimerizing agents
#9623,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof
#963(1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-uanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid hydrates pharmaceutical uses thereof
#964Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine
#965Atrasentan mandelate salts
#966(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#967Optically active axially chiral alpha-allenic alcohol, synthesis method and use thereof
#968Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#969Glucagon antagonists
#970Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#971Kinetic resolution
#972Preparation of ticagrelor
#973Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases
#974Salicylic acid derivatives useful as glucocerebrosidase activators
#975Simple organic molecules as catalysts for practical and efficient enantioselective synthesis of amines and alcohols
#976Ruthenium-based complex catalysts
#977Rhodium catalyst and method for producing amine compound
#978Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases
#979Process for preparing fluoroleucine alkyl esters
#980Crystalline diacylhydrazine and the use thereof
#981Compounds for a controlled release of active perfuming molecules
#982Process for preparing carboxylic acids
#983Process for producing optically active secondary alcohol
#984Benzamide compounds and related methods of use
#985Process for the removal of contaminant from a hydrochlorofluoroolefin by extractive distillation
#986Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst
#987Separating agent and manufacturing method thereof
#988Guanidinobenzoic acid compound
#989Synthesis of triazolopyrimidine compounds
#990Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
#991Method for producing high-purity ceramide
#992Neprilysin inhibitors
#993Versatile and stereospecific synthesis of γ,δ-unsaturated amino acids by Wittig reaction
#994()-6-(dimethylamino)-4,4-diphenylheptan-3-one
#995Stereoselective synthesis of metyrosine
#996Compounds and methods for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
#997Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst
#998Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
#999Process for the preparation of gamma amino acids and intermediates used in said process
#1000Substituted biaryl alkyl amides
#1001Process for preparation of (3)-2,4-di-leaving group-3-methylbut-1-ene
#10025,5-dimethyl-2-propyl-hexahydro-2,4a-methano-naphthalen-1-one as a fragrance agent
#1003Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate
#1004Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
#1005Method for producing optically active alcohols
#1006Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
#1007Enantiomers of 2-hydroxy derivatives of fatty acids
#1008Chiral oligomeric pentenoate amides as bio-oligomer mimetics
#1009Production of adipic acid and derivatives from carbohydrate-containing materials
#1010Process for the preparation of aminoacrylic acid derivatives
#1011Optically active fluconazole analogues containing thiophenes as antifungal agents
#1012Selective hydrogenation of aldehyde with ru/bidentate ligands complexes
#1013Tetrahydronaphthalenyl compounds useful as sipi agonists
#1014Benzamide compounds and related methods of use
#1015Arylated β-dicarbonyl compounds and process for the preparation thereof
#1016Intermediate compounds of tamiflu, methods of preparation and uses thereof
#1017Method for diagnosing infection
#1018Isometheptene isomer
#1019Process for preparing chiral quinone
#1020Alkyl lactyllactates and processes of making the same
#1021Spirobenzylamine-phosphine, preparation method therefor and use thereof
#1022Hydroxybutyrate ester and medical use thereof
#1023Ruthenium complex and method for preparing optically active alcohol compounds using the same as a catalyst
#1024Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid
#1025Process for asymetric methylallylation in the presence of a 2,2′-substituted 1,1′-BI-2-naphthol catalyst
#1026Methods and compositions for the synthesis of multimerizing agents
#1027Catalysts and processes for the hydrogenation of amides
#1028Chiral synthesis of N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[2,3-dihydroxy-propyl]cyclopropanesulfonamides
#1029Synthetic method of enantiomerically pure 2,2′-dihydroxy-1,1′-binaphthyl-3-carboxylic acid
#1030Method for manufacturing optically active carboxylic acid ester
#1031Atropisomeric 1,8-bisphenolnapthalenes and their use in enantioselective recognition and asymmetric synthesis
#1032Disubstituted amino acids and methods of preparation and use thereof
#1033Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
#1034Compounds for use in the treatment of inflammatory bowel disease
#1035Methods of using derivatives of (−)-venlafaxine
#1036Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
#1037Compounds for use in the treatment of immune related inflammatory disease
#1038Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
#1039Process for producing optically active succinimide derivatives and intermediates thereof
#1040Stable crystal modifications of DOTAP chloride
#1041Diazeniumdiolate cyclohexyl derivatives
#1042Method for the preparation of cinacalcet and intermediates and impurities thereof
#1043Isolated compounds from turmeric oil and methods of use
#1044Preparation method for rivastigmine, intermediates thereof, and preparation method for said intermediates
#1045Anhydrous and hemihydrate crystalline forms of an ()-baclofen prodrug, methods of synthesis and methods of use
#1046Method of preparing (S)-2-amino-5-methoxytetralin hydrochloride
#1047Process for producing (3S)-1-menthyl 3-hydroxybutyrate and sensate composition
#1048Process for the preparation of and crystalline forms of optical enantiomers of modafinil
#1049Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
#1050Method for the synthesis of rasagiline
#1051Process for preparing lacosamide
#1052Catalyst for asymmetric hydrogenation of imine, synthesis method and application thereof
#1053Diamino acid derivative starting material, manufacturing method thereof, and diamino acid derivative manufacturing method
#1054Production method of optically active dihydrobenzofuran derivative
#1055Process of isolating enantiomer components from enantiomer mixtures by particle-size-controlled crystallization
#1056Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
#1057(1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentyl-l-carboxylic acid hydrates pharmaceutical uses thereof
#1058PKC-ε activator
#1059Cycloalkyl guanidine FF-ATPase inhibitors and therapeutic uses thereof
#1060Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin Dand related precursors
#1061Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
#1062Diterpenoid derivatives endowed of biological properties
#1063Pharmaceutical compositions comprising monoterpenes
#1064Phenylglyoxylic acid derivatives and their preparation and use
#1065Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
#1066Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
#1067Estrogenic compounds, process for their production and pharmaceutical uses thereof
#1068Neprilysin inhibitors
#1069Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
#1070Method for manufacturing optically active menthol
#1071Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
#1072Synthetic ion channels
#1073Levalbuterol salt
#1074Chiral spiro-pyridylamidophosphine ligand compound, synthesis method therefor and application thereof
#1075Asymmetric synthetic processes for the preparation of aminosulfone compounds
#1076Chiral intermediates useful for the preparation of hydroxyphosphine ligands
#1077Catalyst for asymmetric hydrogenation and method for manufacturing optically active carbonyl compound using the same
#1078SHIP1 modulators and related methods
#1079Process for producing optically active β-amino aldehyde compound
#1080Process for preparing carboxamidine compounds
#1081Dithioamine reducing agents
#1082Process for the enzymatic synthesis of (7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid or esters thereof, and application in the synthesis of ivabradine and salts thereof
#1083Processes for the preparation of fesoterodine
#1084Process for preparing aminoadamantyl carbamate derivatives
#1085Cyclopropylamine derivatives useful as LSD1 inhibitors
#1086Method for preparing optically active 1-bromo-1[3,5-bis(trifluoromethyl)phenyl]ethane
#1087Process for the preparation of amino acid derivatives
#1088Biaryl diphosphine ligands, intermediates of the same and their use in asymmetric catalysis
#1089N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
#1090Preparation method of high-optical purity N2-[1 -(S)-ethoxycarbonyl-3-phenylpropyl]-N6-trifluoroacetyl-L-lysine
#1091Fatty alcohol esters of hydroxycarboxylic acids
#1092Method for producing optically active 1,2-bis(dialkylphosphino)benzene derivative
#1093Method for oxidizing alcohols
#1094Process for the preparation of intermediates useful for the manufacture NEP inhibitors
#1095Optically active ammonium salt compound, production intermediate thereof, and production method thereof
#1096Process for the asymmetric transfer hydrogenation of ketones
#1097Process for the preparation of nitrogen substituted aminotetralins derivatives
#1098Chiral diene ligands, a fabrication method thereof and applications thereof
#1099Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane
#1100Solid state forms of tapentadol salts
#11011-hydroxy-octahydroazulenes as fragrances
#1102Biocatalysts and methods for the synthesis of ()-3-(1-aminoethyl)-phenol
#1103R(+)-N-formyl-propargyl-aminoindan
#1104Separation/detection column and kit thereof
#1105Enantiopure base-metal catalysts for asymmetric catalysis and bis(imino)pyridine iron alkyl complexes for catalysis
#1106Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
#1107Crystalline diacylhydrazine and the use thereof
#1108THERAPEUTIC COMPOSITIONS
#1109Process for the preparation of pleuromutilins
#1110Process for producing Aliskiren
#1111Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
#1112Process for the dehydration of substituted 4-dimethylamino-2-aryl-butan-2-ol compounds and process for the preparation of substituted dimethyl-(3-aryl-butyl)-amine compounds by heterogeneous catalysis
#1113METHOD FOR PRODUCING PRECURSORS FOR L-3,4-DIHYDROXY-6-[18F]FLUOROPHENYLALANINE AND 2-[18F]FLUORO-L-TYROSINE AND THE A-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-3,4DIHYDROXY-6-[18F]FLUOROPHENYLALANINE AND 2-[18F]FLUORO-L-TYROSINE AND THE A-METHYLATED DERIVATIVES FROM THE PRECURSOR
#1114Therapeutic compounds
#1115Asymmetric hydrogenation method for ketone compound
#1116Method for producing optically active, racemic menthol
#1117Cyclisation process of forming a multiple ring compound
#1118Anhydrous and hemihydrate crystalline forms of an ()-baclofen prodrug, methods of synthesis and methods of use
#11193-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#1120ORGANIC/INORGANIC HYBRID CATALYTIC MATERIALS, THEIR PREPARATION, USE IN SELECTIVE PROCESSES AND REACTORS CONTAINING THEM
#1121Process for the preparation of lacosamide
#1122Glucagon antagonists
#1123Desferrithiocin polyether analogues
#1124LEVALBUTEROL SALT
#1125Trivinylcyclohexane stereoisomeric compositions and methods for preparing same
#1126Process for the preparation of DOPO-derived compounds and compositions thereof
#1127Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same
#1128Alcohol production method by reducing ester or lactone with hydrogen
#1129Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
#1130Enantioselective Synthesis of y-amino-a, B-unsuturated carboxylic acid derivatives
#1131Process for synthesis of amino-methyl tetralin derivatives
#1132Cross-coupled peptide nucleic acids for detection of nucleic acids of pathogens
#1133Process for producing (3S)-I-menthyl 3-hydroxybutyrate and sensate composition
#1134Method of resolution of (RS)- 1,1′-BI-2-naphthol for obtaining enantiomeric pure I.E. (S)-(−)-1,1′-BI-2-naphthol and/or (R)-(+)-1,1′-BI-2-naphthol via co-crystal formation with optically active derivatives of γ-amino acids
#1135Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols
#1136Process of preparing chiral diacylhydrazine ligands
#1137Process for the preparation of nitrogen substituted aminotetralins derivatives
#1138Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride
#1139Process for preparation of pure alkyl esters from alkali metal salt of carboxylic acid
#1140Levodopa Prodrugs, and Compositions and Uses Thereof
#1141PROCESS FOR PREPARING OPTICALLY PURE MILNACIPRAN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
#1142Benzyl amines, a process for their production and their use as anti-inflammatory agents
#1143Single diastereomers of 4-fluoroglutamine and methods of their preparation and use
#1144METHOD FOR ISOLATING AN ALKANOL FROM AN AQUEOUS BIOTRANSFORMATION MIXTURE
#1145INTERCONVERSION BETWEEN ISOMERIC P-MENTHANE-3-CARBOXYLIC ACIDS
#1146Intermediate compounds and processes for the preparation of tapentadol and related compounds
#1147Kinetic resolution
#1148Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
#1149PROSTACYCLIN DERIVATIVES
#1150Process for the preparation of enantiomerically pure -leucine
#1151Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
#1152Nuclear Hormone Receptor Modulators
#1153Process for the preparation of tapentadol and intermediates thereof
#1154Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
#1155Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester
#1156Methods of using derivatives of (−)-venlafaxine
#1157Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol
#1158Compounds, pharmaceutical compositions and uses thereof
#1159Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic Acid
#1160Neprilysin inhibitors
#1161TREPROSTINIL PRODUCTION
#1162Therapeutic compounds
#1163Estrogenic compounds, process for their production and pharmaceutical uses thereof
#1164Treprostinil production
#1165Compositions and methods for stereoselective aldehyde allylation and crotylation
#1166COMPOUNDS FOR TREATING DISORDERS OR DISEASES ASSOCIATED WITH NEUROKININ 2 RECEPTOR ACTIVITY
#1167Process for preparation of phenyl carbamate derivatives
#1168Metal-catalysed carbonylation of unsaturated compounds
#1169Process for preparing octenoic acid derivatives
#1170Substituted cyclopentanes having prostaglandin activity
#1171Methods for preparation of glycosphingolipids and uses thereof
#1172PRODRUGS OF GUANFACINE
#1173ANGIOGENIC RESORCINOL DERIVATIVES
#1174Optically active diazabicyclooctane derivatives and process for preparing the same
#1175Tryptophan hydroxylase inhibitors
#1176PROCESS FOR PREPARING PREGABALIN
#1177Method for synthesis of secondary alcohols
#1178CATHEPSIN C INHIBITORS
#1179Catalyst for asymmetric hydrogenation and method for manufacturing optically active carbonyl compound using the same
#1180Processes for the preparation of optically active intermediates
#1181NANOSTRUCTURED METALS
#1182Treatment of CNS disorders with 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
#1183Substituted acylanilides and methods of use thereof
#1184ENZYMES AND METHODS FOR RESOLVING AMINO VINYL CYCLOPROPANE CARBOXYLIC ACID DERIVATIVES
#1185PROCESS FOR THE PREPARATION OF CYCLOPROPYL CARBOXYLIC ACID ESTERS AND DERIVATIVES
#1186Inhibitors of cognitive decline
#1187New Anthraquinone Derivatives
#1188Desfesoterodine in the form of a tartaric acid salt
#1189Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same
#1190Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
#1191Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
#11924-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#1193S-t-butyl protected cysteine di-peptide analogs and related compounds
#1194PROCESS FOR MAKING NEO-ENRICHED p-MENTHANE COMPOUNDS
#1195Process for the preparation of functionalised benzocyclobutenes, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
#1196Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
#1197Synthesis of tetracyclines and intermediates thereto
#1198Lipoxin analogs and methods for the treatment of periodontal disease
#1199Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same
#1200Sitagliptin synthesis